Fundraising Fox

Serif Biomedicines

Cambridge, US · 2 known investors

Serif Biomedicines develops DNA-based therapies and nucleic acid delivery technologies for genetic medicine. The company aims to create tailored, long-acting treatments across multiple diseases.

BiotechDeep TechDigital HealthMedical Devices

Founders & leadership

JR
Jacob RubensinChief Executive Officer

Investors · 2

Flagship PioneeringCambridge · $500K – $10M
Modi VenturesHouston

In the news

Top Biotech VC Firms 2026: Leading Biotech Startup Investors Guidequbit.capital · Apr 2026Flagship’s latest startup aims to solve gene therapy’s thorniest technical challengeendpoints.news · Apr 2026Serif Biomedicines launches to reformat DNA medicinescen.acs.org · Apr 2026Serif, Flagship’s latest biotech, aims to make a new kind of genetic medicine | BioPharma Divebiopharmadive.com · Apr 2026

Frequently asked questions

What does Serif Biomedicines do?
Serif Biomedicines develops DNA-based therapies and nucleic acid delivery technologies for genetic medicine. The company aims to create tailored, long-acting treatments across multiple diseases.
Who are Serif Biomedicines's investors?
Serif Biomedicines's investors include Flagship Pioneering, Modi Ventures.
Where is Serif Biomedicines headquartered?
Serif Biomedicines is headquartered in Cambridge, US.